Data as of Mar 07
| -0.52 / -1.04%|
The 16 analysts offering 12-month price forecasts for Teva Pharmaceutical Industries Ltd have a median target of 45.00, with a high estimate of 58.00 and a low estimate of 38.00. The median estimate represents a -8.72% decrease from the last price of 49.30.
The current consensus among 23 polled investment analysts is to Hold stock in Teva Pharmaceutical Industries Ltd. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.